CLINICAL_TRIALS
trial_result
· 2017-12-21
Clinical Trial Update: A Study of Golimumab in Participants With Active Psoriatic Arthritis [Phase 3]
Summary
Phase 3 trial update for golimumab in active psoriatic arthritis has completed; results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Arthritis, Psoriatic | Phase 3 | Status: COMPLETED | Results posted: 2017-12-21